Johnson & Johnson Ranks 43rd in Market Activity with $1.779 Billion Trading Volume

On July 23, 2025, Johnson & Johnson (JNJ) saw a trading volume of $1.779 billion, ranking 43rd in the day's market activity. The stock rose by 0.70%, marking its fourth consecutive day of gains, with a total increase of 3.76% over the past four days.

Johnson & Johnson has been a focal point for investors, with its stock performance closely watched. Over the past month, the company's shares have returned 8.6%, outperforming the S&P 500 composite's 5.9% change. However, the Zacks Large Cap Pharmaceuticals industry, to which Johnson & Johnson belongs, has seen a slight decline of 0.1% during the same period.

Earnings estimates play a crucial role in determining the stock's future direction. Johnson & Johnson is expected to report earnings of $2.77 per share for the current quarter, reflecting a year-over-year increase of 14.5%. The consensus earnings estimate for the current fiscal year is $10.83, indicating an 8.5% year-over-year change. For the next fiscal year, the consensus estimate is $11.33, a 4.6% increase from the previous year.

Johnson & Johnson's revenue growth is also a key indicator of its financial health. The consensus sales estimate for the current quarter is $23.64 billion, representing a 5.2% year-over-year increase. For the current and next fiscal years, the estimates are $93.42 billion and $96.78 billion, respectively, indicating changes of 5.2% and 3.6%.

In the last reported quarter, Johnson & Johnson reported revenues of $23.74 billion, a 5.8% year-over-year increase. The earnings per share (EPS) for the same period was $2.77, compared to $2.82 a year ago. The company exceeded consensus revenue and EPS estimates, showing a surprise of 4.13% and 4.14%, respectively. Johnson & Johnson has consistently beaten consensus EPS estimates in each of the trailing four quarters.

Johnson & Johnson's stock is currently graded B on the Zacks Value Style Score, indicating that it is trading at a discount to its peers. This valuation suggests that the stock may be undervalued, making it an attractive investment opportunity.